Pfizer, NCI Form Anti-Cancer Study Pact
By

By
Pfizer has formed a collaboration with the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to work with NCI’s Center for Cancer Research to arrange and…

Roche Launches Cancer-Study Network, Invests $100 Million
By

By
Roche has launched the Centers of Research Excellence (imCORE) Network, a global cancer immunotherapy network that brings together scientific and clinical experts in cancer immunotherapy to collaborate in investigating new…

Biogen Appoints Executives to Spin-Off Company
By

By
Biogen has appointed two members to the executive management team of Bioverativ Inc., Biogen’s planned spin-off company focused on the discovery, research, development, and commercialization of treatments for hemophilia and…

Sanofi Genzyme Opts-In on Hemophilia Drug
By

By
Sanofi Genzyme, the specialty care global business unit of Sanofi, has opted in with Alnylam Pharmaceuticals, a Cambridge, Massachusetts-based biopharmaceutical company focused on RNAi therapeutics, to co-develop (through Sanofi research…

Almac Invests $34 Million in Expansion
By

By
Almac Group, a contract pharmaceutical development and manufacturing organization headquartered in Craigavon, Northern Ireland, has announced plans to expand its operations in Europe and North America and to increase its…

Pfizer to Close Two UK Plants
By

By
Pfizer has proposed closing two of its UK supply facilities following a review of its global supply network, the company said in a statement distributed to the media. The company…

Recipharm Invests $1.3 Million in API Facility
By

By
Recipharm, a contract development and manufacturing organization based in Jordbro, Sweden, has invested more than EUR1.2 million ($1.3 million) to enhance its small-scale GMP active pharmaceutical ingredient development and manufacturing…

VWR Buys API Firm and Serum Company
By

By
VWR, a Radnor, Pennsylvania-headquartered provider of product and service solutions, has acquired two companies, Reliable Biopharmaceutical, an Overland, Missouri-based active pharmaceutical ingredient (API) manufacturer, and BioArra, an Eagleville, Pennsylvania-based producer…

UPS to Acquire Marken
By

By
UPS, the shipping firm, has agreed to acquire Marken, a Research Triangle Park, North Carolina-based provider of logistic and supply-chain services for clinical trial materials. Financial terms of the acquisition…

Selexis, Xencor Partner
By

By
Selexis, a Geneva, Switzerland-based life-sciences company focused on mammalian (suspension-adapted CHO-K1) cell line generation, has formed a new strategic agreement with Xencor, a Monrovia, California-based clinical-stage biopharmaceutical company developing engineered…